These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35180865)
1. NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression. Sun H; Zhang H; Yan Y; Li Y; Che G; Zhou C; Nicot C; Ma H Mol Cancer; 2022 Feb; 21(1):55. PubMed ID: 35180865 [TBL] [Abstract][Full Text] [Related]
2. Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer. Zheng T; Qian T; Zhou H; Cheng Z; Liu G; Huang C; Dou R; Liu F; You X Aging (Albany NY); 2023 Jun; 15(12):5535-5549. PubMed ID: 37335105 [TBL] [Abstract][Full Text] [Related]
3. Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration. Zhang Q; Su R; Shan C; Gao C; Wu P Oncol Res; 2018 Mar; 26(2):269-276. PubMed ID: 29046167 [TBL] [Abstract][Full Text] [Related]
4. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer Chen Y; Yang S; Zhou H; Su D Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916 [TBL] [Abstract][Full Text] [Related]
5. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094 [No Abstract] [Full Text] [Related]
6. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3. Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705 [TBL] [Abstract][Full Text] [Related]
7. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230 [TBL] [Abstract][Full Text] [Related]
8. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling. Jin X; Liu X; Zhang Z; Xu L Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856 [TBL] [Abstract][Full Text] [Related]
9. B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer. Jin Y; Zhu H; Cai W; Fan X; Wang Y; Niu Y; Song F; Bu Y Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555007 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression. Guo D; Wang Y; Ren K; Han X Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway. Yu H; Zou D; Ni N; Zhang S; Zhang Q; Yang L J Ovarian Res; 2022 Aug; 15(1):98. PubMed ID: 35986371 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y; Ni R; Wang J; Liu Y Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440 [TBL] [Abstract][Full Text] [Related]
13. NCAPG deregulation indicates poor patient survival and contributes to colorectal carcinogenesis. Sun DP; Wu CC; Chou CL; Cheng LC; Wang WC; Lin SS; Hung ST; Tian YF; Fang CL; Lin KY Pathol Res Pract; 2023 Jan; 241():154238. PubMed ID: 36442414 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma. Wang X; Tian X; Sui X; Li X; Zhao X; Han K; Sun L; Dong Y Bioengineered; 2022 Mar; 13(3):6113-6125. PubMed ID: 35254214 [TBL] [Abstract][Full Text] [Related]
15. MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7. Xiang J; Hang JB; Che JM; Li HC Int J Clin Exp Pathol; 2015; 8(8):9147-53. PubMed ID: 26464659 [TBL] [Abstract][Full Text] [Related]
16. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer. Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243 [TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer. Wang L; Kong W; Liu B; Zhang X Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172 [TBL] [Abstract][Full Text] [Related]
18. Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation. Hou J; Huang P; Xu M; Wang H; Shao Y; Weng X; Liu Y; Chang H; Zhang L; Cui H Neuro Oncol; 2023 Nov; 25(11):2015-2027. PubMed ID: 37422706 [TBL] [Abstract][Full Text] [Related]
19. RNA sequencing reveals the transcriptomic landscape and alternative splicing events induced by LGALS1 silencing in non-small cell lung cancer. Shi H; Zhang Y; Liu J; Wang Y; Fang P Adv Clin Exp Med; 2024 Jan; 33(1):79-90. PubMed ID: 37341175 [TBL] [Abstract][Full Text] [Related]
20. NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway. Tang F; Yu H; Wang X; Shi J; Chen Z; Wang H; Wan Z; Fu Q; Hu X; Zuhaer Y; Liu T; Yang Z; Peng J Biochem Biophys Res Commun; 2022 Sep; 622():101-107. PubMed ID: 35843088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]